HOME > TOP STORIES
TOP STORIES
-
REGULATORY “Third Price Revision” Eyed for Expansion of Comparator PMP Deduction Rule
December 11, 2019
-
BUSINESS Healios Poised to Go into the Black with Sakigake-Designated MultiStem, Revs Up Universal Cell Biz
December 10, 2019
-
REGULATORY Metformin Manufacturers Ordered to Test for Potential Carcinogen Contamination
December 10, 2019
-
REGULATORY Pharma Industry Might Accept Comparator PMP Deduction If No Eligible Use Added in 6 Years
December 9, 2019
-
REGULATORY Big 4 Wholesalers Faced Wrath of FTC for Allocating Priority Drug Categories before Bidding
December 6, 2019
-
COMMENTARY Course of Govt’s “All-Generation” Social Security Reform Could Impact Pharma
December 5, 2019
-
REGULATORY Average NHI-Market Price Gap at 8.0%, Suspected Bid-Rigging Data Excluded: Chuikyo
December 4, 2019
-
BUSINESS With Audentes Buyout, Astellas Poised to Position “Genetic Regulation” as 5th Biz Pillar
December 4, 2019
-
BUSINESS Astellas to Buy Gene Therapy Player Audentes for US$3 Billion
December 3, 2019
-
REGULATORY Causal Link between Eisai’s Epilepsy Drug and Trial Death Can’t Be Ruled Out: MHLW
December 2, 2019
-
BUSINESS Stakeholders Rap Big 4 Wholesalers for Bid-Rigging Charges, Say Scandal Shutters Trust in Drug Price Surveys
November 29, 2019
-
BUSINESS 10-Plus Japan Drug Makers Up FY2019 Guidance on Bullish New Drugs, Mainstays: Tally
November 29, 2019
-
REGULATORY Amended PMD Law Set for 3-Step Enforcement, 1st Execution Eyed Next Autumn
November 28, 2019
-
BUSINESS Big 4 Drug Wholesalers Raided on Bid-Rigging Charges
November 28, 2019
-
REGULATORY Japan’s First Biosimilars of Avastin, Nesp, Forteo Receive Listing
November 27, 2019
-
BUSINESS Asahi Kasei to Buy Veloxis for 143.2 Billion Yen, Eyes US Transplant Market
November 26, 2019
-
REGULATORY MOF Panel Leery of Pricey Drugs for Huge Patient Population: FY2020 Budget Recommendation
November 26, 2019
-
REGULATORY Xolair’s Pollen Allergy Nod Delayed as Novartis Says It Needs More Time to Prepare for Launch
November 25, 2019
-
REGULATORY MHLW Wants to Ease Unfairness Concerns by Adding New Innovation Gauge to PMP Company Criteria
November 25, 2019
-
COMMENTARY Unison Capital Shows Rising Presence with Kyowa Deal, PE Fund Potential Catalyst for Industry Shakeup?
November 22, 2019
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
